Endothelin in congestive heart failure

[1]  D. Webb,et al.  Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors. , 1996, Circulation.

[2]  A. Lerman,et al.  Enhanced Coronary Vasoconstriction to Endothelin-BReceptor Activation in Experimental Congestive Heart Failure , 1996 .

[3]  A. Lerman,et al.  Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. , 1996, Circulation.

[4]  P. Hunziker,et al.  Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure , 1995, The Lancet.

[5]  B. Löffler,et al.  Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). , 1994, Circulation.

[6]  D. Webb,et al.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1. , 1994, The Journal of clinical investigation.

[7]  D. Webb,et al.  Contribution of endogenous generation of endothelin-1 to basal vascular tone , 1994, The Lancet.

[8]  H. Drexler,et al.  Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition. , 1994, British heart journal.

[9]  M. Yanagisawa,et al.  ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 , 1994, Cell.

[10]  J. Cleland,et al.  Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? , 1994, The Lancet.

[11]  T. Rabelink,et al.  Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. , 1994, Kidney international.

[12]  W. Kannel,et al.  Changing epidemiological features of cardiac failure. , 1994, British heart journal.

[13]  K. Tanzawa,et al.  Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. , 1994, The Journal of biological chemistry.

[14]  W. Neidhart,et al.  Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. , 1994, The Journal of pharmacology and experimental therapeutics.

[15]  C. Jones,et al.  Large arteries are more than passive conduits. , 1994, British heart journal.

[16]  P. Vallance,et al.  Human saphenous vein contains both endothelin ETA and ETB contractile receptors. , 1994, European journal of pharmacology.

[17]  M. Kinoshita,et al.  Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.

[18]  T. Lüscher,et al.  Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. , 1994, Hypertension.

[19]  W. Edwards,et al.  Endothelin in human congestive heart failure. , 1994, Circulation.

[20]  H. Krum,et al.  SPONTANEOUS ENDOTHELIN PRODUCTION BY CIRCULATING MONONUCLEAR CELLS FROM PATIENTS WITH CHRONIC HEART FAILURE BUT NOT FROM NORMAL SUBJECTS , 1994, Clinical and experimental pharmacology & physiology.

[21]  J. Townend,et al.  Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure. , 1994, International journal of cardiology.

[22]  M. Yanagisawa.  The endothelin system. A new target for therapeutic intervention. , 1994, Circulation.

[23]  L. V. von Segesser,et al.  Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. , 1994, Circulation.

[24]  P. Vallance,et al.  Endothelin receptors mediating functional responses in human small arteries and veins , 1994, British journal of pharmacology.

[25]  J. McMurray,et al.  Fortnightly Review: Diagnosis and management of heart failure , 1994, BMJ.

[26]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[27]  A. Davenport,et al.  Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? , 1994, Trends in pharmacological sciences.

[28]  A. Carayon,et al.  Plasma endothelin and pulmonary pressures in patients with congestive heart failure. , 1993, American heart journal.

[29]  W. Neidhart,et al.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist , 1993, Nature.

[30]  D. Kohan.  Endothelins in the kidney: physiology and pathophysiology. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  M. Lerner,et al.  Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. , 1993, The Journal of biological chemistry.

[32]  M. Shichiri,et al.  Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. , 1993, Biochemical and biophysical research communications.

[33]  T. Hedner,et al.  Decreased Density of Mesenteric Arteries but not of Myocardial Endothelin Receptors and Function in Rats with Chronic Ischemic Heart Failure , 1993, Journal of cardiovascular pharmacology.

[34]  J. Rouleau,et al.  Regulation of the endothelin-1 transmembrane signaling pathway: the potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure. , 1993, Journal of molecular and cellular cardiology.

[35]  V. Breu,et al.  Downregulation of endothelin receptors by autocrine production of endothelin-1. , 1993, The American journal of physiology.

[36]  H. Teufelsbauer,et al.  Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. , 1993, The American journal of cardiology.

[37]  D. Webb,et al.  The endothelin family of peptides: local hormones with diverse roles in health and disease? , 1993, Clinical science.

[38]  S. Roux,et al.  Influence of congestive heart failure on endothelin levels and receptors in rabbits. , 1993, Journal of molecular and cellular cardiology.

[39]  N. Brière,et al.  Growth regulatory properties of endothelins , 1993, Peptides.

[40]  A. Davenport,et al.  Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue , 1992, Journal of hypertension.

[41]  A. Lerman,et al.  Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. , 1992, Journal of the American College of Cardiology.

[42]  B. Binder,et al.  Polar secretion of endothelin-1 by cultured endothelial cells. , 1992, The Journal of biological chemistry.

[43]  R. Rodeheffer,et al.  Increased plasma concentrations of endothelin in congestive heart failure in humans. , 1992, Mayo Clinic proceedings.

[44]  M. Packer.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[45]  D. Hayoz,et al.  Endothelial function in chronic congestive heart failure. , 1992, The American journal of cardiology.

[46]  M. Dunn,et al.  The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. , 1992, The Journal of laboratory and clinical medicine.

[47]  J. McMurray,et al.  Plasma Endothelin in Chronic Heart Failure , 1992, Circulation.

[48]  W. Waldhäusl,et al.  Regional Hemodynamic Effects and Clearance of Endothelin‐1 in Humans: Renal and Peripheral Tissues May Contribute to the Overall Disposal of the Peptide , 1992, Journal of cardiovascular pharmacology.

[49]  P. Binkley,et al.  Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.

[50]  J. Rouleau,et al.  Elevated Endothelin‐1 in Heart Failure and Loss of Normal Response to Postural Change , 1992, Circulation.

[51]  F. Marumo,et al.  Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.

[52]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[53]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[54]  M. Shichiri,et al.  Cellular Mechanism of Endothelin‐1 Release by Angiotensin and Vasopressin , 1991, Hypertension.

[55]  G. Thibault,et al.  Renal glomerular endothelin receptors in rats with high-output heart failure , 1991, Regulatory Peptides.

[56]  A. Lerman,et al.  Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.

[57]  G. Bakris,et al.  Arginine vasopressin stimulates human mesangial cell production of endothelin. , 1991, The Journal of clinical investigation.

[58]  D. Webb,et al.  Pharmacology of endothelin-1 in vivo in humans. , 1991, Journal of Cardiovascular Pharmacology.

[59]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[60]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[61]  A. Ristimäki,et al.  Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. , 1990, Biochemical and biophysical research communications.

[62]  E. Ohlstein,et al.  Renal microvascular effects of endothelin. , 1990, The American journal of physiology.

[63]  T. Resink,et al.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. , 1990, Cell regulation.

[64]  H. Yasuda,et al.  Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. , 1990, Journal of molecular and cellular cardiology.

[65]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[66]  L. V. von Segesser,et al.  Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? , 1990, Circulation.

[67]  W. Waldhäusl,et al.  Effect of endothelin-1 in man. , 1990, Circulation.

[68]  T. Lüscher,et al.  Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. , 1990, The Journal of clinical investigation.

[69]  R. O. Banks,et al.  Cardiorenal actions of endothelin, Part I: Effects of converting enzyme inhibition. , 1990, Life sciences.

[70]  D. Webb,et al.  Endothelin is a potent long-lasting vasoconstrictor in men. , 1989, The American journal of physiology.

[71]  P. Braquet,et al.  Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. , 1989, Biochemical and biophysical research communications.

[72]  M. Cantin,et al.  Relaxing Effect of Atrial Natriuretic Factor on Endothelin-Precontracted Vascular Strips , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[73]  R. Alexander,et al.  Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. , 1989, The Journal of biological chemistry.

[74]  M. Yanagisawa,et al.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[75]  T. Masaki,et al.  A sensitive sandwich-enzyme immunoassay for human endothelin. , 1989, Journal of immunological methods.

[76]  G. Dubyak,et al.  Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. , 1989, The Journal of clinical investigation.

[77]  M. Redfield,et al.  Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.

[78]  M. Boarder,et al.  Characterization of Endothelin‐1 Stimulation of Catecholamine Release from Adrenal Chromaffin Cells , 1989, Journal of cardiovascular pharmacology.

[79]  T. Resink,et al.  Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. , 1988, Biochemical and biophysical research communications.

[80]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[81]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[82]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[83]  J. Cohn,et al.  The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.

[84]  P. Vanhoutte.  Adjustments in the peripheral circulation in chronic heart failure. , 1983, European heart journal.

[85]  R. Zelis,et al.  Alterations in vasomotor tone in congestive heart failure. , 1982, Progress in cardiovascular diseases.

[86]  J. Longhurst,et al.  A Comparison of Regional Blood Flow and Oxygen Utilization During Dynamic Forearm Exercise in Normal Subjects and Patients with Congestive Heart Failure , 1974, Circulation.